Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Orchid Pharma Ltd.

Orchid Pharma

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
22 05 2021 Audited Results
15 07 2021 inter-alia, to consider and approve: Fund raising by way of issuance of equity shares through preferential allotment/private placement in single/multiple tranches.
13 08 2021 Quarterly Results
14 11 2021 Quarterly Results
12 02 2022 Quarterly Results
12 05 2022 Audited Results
10 08 2022 Quarterly Results
14 11 2022 Quarterly Results
01 12 2022 Inter alia, to consider and approve, amongst other things, raising of funds and issuance of securities through Qualified Institutions Placement basis or through any other permissible mode, in one or more tranches, subject to applicable laws and necessary approval from the shareholders and other regulatory authorities, as may be required.
09 02 2023 Quarterly Results
10 05 2023 Audited Results
10 08 2023 Quarterly Results
04 11 2023 Quarterly Results
08 02 2024 Quarterly Results
11 11 2024 Quarterly Results
12 02 2025 Quarterly Results
26 05 2025 Audited Results

News

02-DEC-2022

Orchid Pharma gets board’s nod to raise Rs 500 crore through QIP

With this QIP placement, the Dhanuka group, which took over the Company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the Company by March 2023

02:10 PM
04-MAR-2023

Orchid Pharma’s arm inks MoU with overseas technology provider

The company has signed MoU for in-licensing 7ACA technology

05:23 PM
12-SEP-2023

Orchid Pharma inks manufacturing sublicense agreement with GARDP

This agreement is to manufacture Cefiderocol

04:47 PM
18-JUL-2022

Orchid Pharma’s arm gets nod to manufacture product ‘7 ACA’ with committed capacity

This approval will help the Company in backward integration, reduce dependency on sourcing from China and aid in improving margins

12:17 PM
18-JUL-2025

Orchid Pharma executes Deed of Hypothecation for Rs 142.50 crore loan facility

The loan is for setting up the Cefiderocol Project

02:40 PM
20-FEB-2025

USFDA concludes inspection at API manufacturing facility of Orchid Pharma

The company’s facility has received seven minor observations

10:17 AM
Enrich money logo